Celldex Therapeutics Inc (CLDX) Insider Trading
- $899,201.80
- $18,911,180.76
- Nov. 11, 2024
- Samuel Bates Martin
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 11, 2024 | CEO | 11,500 | $26.82 | Buy | $308,430.00 | |
June 14, 2024 | VP | 30,000 | $34.87 | Sell | $1,046,100.00 | |
June 14, 2024 | CFO | 17,172 | $35.42 | Sell | $608,232.24 | |
June 7, 2024 | SVP | 45,000 | $35.26 | Sell | $1,586,700.00 | |
June 7, 2024 | VP | 15,000 | $35.06 | Sell | $525,900.00 | |
June 3, 2024 | VP | 46,844 | $33.72 | Sell | $1,579,579.68 | |
May 30, 2024 | SVP | 38,719 | $34.07 | Sell | $1,319,156.33 | |
May 30, 2024 | VP | 38,597 | $33.64 | Sell | $1,298,403.08 | |
May 30, 2024 | CFO | 35,000 | $34.05 | Sell | $1,191,750.00 | |
Aug. 17, 2022 | SVP | 31,312 | $36.73 | Sell | $1,150,089.76 | |
Aug. 12, 2022 | CFO | 17,547 | $36.45 | Sell | $639,588.15 | |
Dec. 23, 2021 | CFO | 9,500 | $42.00 | Sell | $399,000.00 | |
Dec. 8, 2021 | VP | 4,000 | $40.00 | Sell | $160,000.00 | |
Dec. 8, 2021 | SVP | 7,323 | $40.00 | Sell | $292,920.00 | |
Nov. 15, 2021 | CFO | 9,500 | $43.57 | Sell | $413,915.00 | |
Nov. 12, 2021 | SVP | 4,600 | $42.94 | Sell | $197,524.00 | |
Aug. 11, 2021 | SVP | 430 | $46.28 | Buy | $19,900.40 | |
Aug. 10, 2021 | CFO | 2,738 | $45.25 | Sell | $123,894.50 | |
Dec. 14, 2020 | VP | 20,832 | $18.61 | Sell | $387,683.52 | |
June 11, 2020 | SVP | 2,115 | $4.73 | Buy | $10,003.95 | |
June 9, 2020 | CFO | 9,750 | $2.99 | Buy | $29,152.50 | |
June 9, 2020 | VP | 5,000 | $2.99 | Buy | $14,950.00 | |
June 9, 2020 | SVP | 1,000 | $2.99 | Buy | $2,990.00 | |
June 9, 2020 | Director | 8,305 | $2.99 | Buy | $24,831.95 | |
June 9, 2020 | CEO | 15,000 | $2.99 | Buy | $44,850.00 | |
Aug. 24, 2018 | Director | 40,000 | $0.48 | Buy | $19,200.00 | |
June 15, 2018 | VP | 16,500 | $0.59 | Buy | $9,735.00 | |
Sept. 2, 2016 | VP | 3,000 | $3.32 | Buy | $9,960.00 | |
Nov. 23, 2015 | CFO | 25,000 | $18.00 | Sell | $450,000.00 | |
Aug. 25, 2015 | Director | 5,000 | $14.00 | Buy | $70,000.00 | |
Aug. 20, 2015 | Director | 5,000 | $15.00 | Buy | $75,000.00 | |
Aug. 18, 2015 | Director | 5,000 | $15.95 | Buy | $79,750.00 | |
Aug. 13, 2015 | Director | 5,000 | $16.59 | Buy | $82,950.00 | |
Aug. 13, 2015 | CEO | 5,800 | $16.81 | Buy | $97,498.00 | |
June 15, 2015 | CFO | 25,000 | $24.59 | Sell | $614,750.00 | |
Dec. 6, 2013 | CFO | 183,333 | $24.50 | Sell | $4,491,658.50 | |
Dec. 6, 2013 | Director | 17,728 | $24.50 | Sell | $434,336.00 |
Insiders are both buying and selling Celldex Therapeutics Inc stock.
The insider traders at Celldex Therapeutics Inc are: Samuel Bates Martin, Larry Ellberger, Elizabeth Crowley, Diane C Young, Tibor Keler, James J Marino, Anthony S Marucci, Margo Heath-Chiozzi, Sarah Cavanaugh, Avery W Catlin, Anthony S. Marucci, Richard M Wright, Richard M. Wright, Avery W. Catlin, Freddy A Jimenez, and Avery Catlin
The most active insider trader at Celldex Therapeutics Inc is Samuel Bates Martin with 7 trades.
Avery Catlin has sold the most Celldex Therapeutics Inc stock with a total value of $8,983,317.00.
Anthony S Marucci has bought the most Celldex Therapeutics Inc stock with a total value of $714,358.00.
The most recent insider trade for Celldex Therapeutics Inc was on Nov. 11, 2024.
The single biggest insider buy for Celldex Therapeutics Inc was from Anthony S Marucci with a total value of $308,430.00 on Nov. 11, 2024.
The single biggest insider sell for Celldex Therapeutics Inc was from Avery Catlin with a total value of $4,491,658.50 on Dec. 6, 2013.